BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29847141)

  • 1. Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Bradycardiac Effects Caused by Co-Administration of Sofosbuvir and Amiodarone.
    Yu Y; Liu F; He L; Ramakrishna S; Zheng M; Bu L; Xu Y
    Assay Drug Dev Technol; 2018; 16(4):222-229. PubMed ID: 29847141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Drug-Drug Interactions In Vitro: A Case Study Evaluating the Effects of Sofosbuvir and Amiodarone on hiPSC-Derived Cardiomyocytes.
    Millard DC; Strock CJ; Carlson CB; Aoyama N; Juhasz K; Goetze TA; Stoelzle-Feix S; Becker N; Fertig N; January CT; Anson BD; Ross JD
    Toxicol Sci; 2016 Nov; 154(1):174-182. PubMed ID: 27503387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between amiodarone and hepatitis-C virus nucleotide inhibitors in human induced pluripotent stem cell-derived cardiomyocytes and HEK-293 Cav1.2 over-expressing cells.
    Lagrutta A; Zeng H; Imredy J; Balasubramanian B; Dech S; Lis E; Wang J; Zhai J; DeGeorge J; Sannajust F
    Toxicol Appl Pharmacol; 2016 Oct; 308():66-76. PubMed ID: 27520758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac drug-drug interaction between HCV-NS5B pronucleotide inhibitors and amiodarone is determined by their specific diastereochemistry.
    Lagrutta A; Regan CP; Zeng H; Imredy JP; Koeplinger K; Morissette P; Liu L; Wollenberg G; Brynczka C; Lebrón J; DeGeorge J; Sannajust F
    Sci Rep; 2017 Mar; 7():44820. PubMed ID: 28327633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amniotic membrane as novel scaffold for human iPSC-derived cardiomyogenesis.
    Parveen S; Singh SP; Panicker MM; Gupta PK
    In Vitro Cell Dev Biol Anim; 2019 Apr; 55(4):272-284. PubMed ID: 30798515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch.
    Khan M; Xu Y; Hua S; Johnson J; Belevych A; Janssen PM; Gyorke S; Guan J; Angelos MG
    PLoS One; 2015; 10(5):e0126338. PubMed ID: 25993466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological enhancement of repolarization reserve in human induced pluripotent stem cells derived cardiomyocytes.
    Treat JA; Goodrow RJ; Bot CT; Haedo RJ; Cordeiro JM
    Biochem Pharmacol; 2019 Nov; 169():113608. PubMed ID: 31465775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting HIF-1α in combination with PPARα activation and postnatal factors promotes the metabolic maturation of human induced pluripotent stem cell-derived cardiomyocytes.
    Gentillon C; Li D; Duan M; Yu WM; Preininger MK; Jha R; Rampoldi A; Saraf A; Gibson GC; Qu CK; Brown LA; Xu C
    J Mol Cell Cardiol; 2019 Jul; 132():120-135. PubMed ID: 31082397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Electrophysiological identification of human induced pluripotent stem cell-derived cardiomyocytes].
    Zhang HY; Zhang TT; Machuki JO; Wu LJ; Sun H
    Sheng Li Xue Bao; 2018 Jun; 70(3):281-286. PubMed ID: 29926069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-Specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia.
    Sasaki K; Makiyama T; Yoshida Y; Wuriyanghai Y; Kamakura T; Nishiuchi S; Hayano M; Harita T; Yamamoto Y; Kohjitani H; Hirose S; Chen J; Kawamura M; Ohno S; Itoh H; Takeuchi A; Matsuoka S; Miura M; Sumitomo N; Horie M; Yamanaka S; Kimura T
    PLoS One; 2016; 11(10):e0164795. PubMed ID: 27764147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extreme bradycardia after first doses of sofosbuvir and daclatasvir in patients receiving amiodarone: 2 cases including a rechallenge.
    Renet S; Chaumais MC; Antonini T; Zhao A; Thomas L; Savoure A; Samuel D; Duclos-Vallée JC; Algalarrondo V
    Gastroenterology; 2015 Nov; 149(6):1378-1380.e1. PubMed ID: 26253303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of gentamicin and penicillin/streptomycin on the electrophysiology of human induced pluripotent stem cell-derived cardiomyocytes in manual patch clamp and multi-electrode array system.
    Hyun SW; Kim BR; Lin D; Hyun SA; Yoon SS; Seo JW
    J Pharmacol Toxicol Methods; 2018; 91():1-6. PubMed ID: 29288713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the clinical cardiac drug-drug interaction associated with the combination of hepatitis C virus nucleotide inhibitors and amiodarone in guinea pigs and rhesus monkeys.
    Regan CP; Morissette P; Regan HK; Travis JJ; Gerenser P; Wen J; Fitzgerald K; Gruver S; DeGeorge JJ; Sannajust FJ
    Hepatology; 2016 Nov; 64(5):1430-1441. PubMed ID: 27474787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrigel Mattress: A Method for the Generation of Single Contracting Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Feaster TK; Cadar AG; Wang L; Williams CH; Chun YW; Hempel JE; Bloodworth N; Merryman WD; Lim CC; Wu JC; Knollmann BC; Hong CC
    Circ Res; 2015 Dec; 117(12):995-1000. PubMed ID: 26429802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patch-Clamp Recording from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Improving Action Potential Characteristics through Dynamic Clamp.
    Verkerk AO; Veerman CC; Zegers JG; Mengarelli I; Bezzina CR; Wilders R
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28867785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biophysical comparison of sodium currents in native cardiac myocytes and human induced pluripotent stem cell-derived cardiomyocytes.
    Goodrow RJ; Desai S; Treat JA; Panama BK; Desai M; Nesterenko VV; Cordeiro JM
    J Pharmacol Toxicol Methods; 2018; 90():19-30. PubMed ID: 29128504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binary Colloidal Crystals Drive Spheroid Formation and Accelerate Maturation of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Cui C; Wang J; Qian D; Huang J; Lin J; Kingshott P; Wang PY; Chen M
    ACS Appl Mater Interfaces; 2019 Jan; 11(4):3679-3689. PubMed ID: 30614683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolite signatures of doxorubicin induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes.
    Chaudhari U; Ellis JK; Wagh V; Nemade H; Hescheler J; Keun HC; Sachinidis A
    Amino Acids; 2017 Dec; 49(12):1955-1963. PubMed ID: 28421296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel purification method of murine embryonic stem cell- and human-induced pluripotent stem cell-derived cardiomyocytes by simple manual dissociation.
    Shinozawa T; Furukawa H; Sato E; Takami K
    J Biomol Screen; 2012 Jun; 17(5):683-91. PubMed ID: 22274911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
    Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
    Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.